Showing 1 - 6 of 6 Transplant%20Trials

Status: Enrolling

Investigator: Ahmed Gaber

Study Coordinator:

Phone:

Kidney transplantation is a good treatment option for people with kidney disease. However, there is still much to learn about how to best care for the transplanted kidney and keep it functioning for a long time. Transplant recipients receive ind ... Read more >

Status: Enrolling

Investigator: Ahmed Gaber

Study Coordinator: Marcos De Oliveira

Phone: 171.344.19837

This is a randomized, double-blind, placebo-controlled trial in de novo kidney transplant patients to determine if the addition of fingolimod (brand name Gilenya®, candidate name- FTY720) on the background of standard immunosuppression will prev ... Read more >

Status: Open Not Enrolling

Investigator: Nabil Tariq

Study Coordinator:

Phone:

This study is designed to evaluate the post-operative complications and re-herniations following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.</ ... Read more >

Status: Enrolling

Investigator: Ahmed Gaber

Study Coordinator: Deborah Pokrass

Phone: 713.441.4490

An open-label, controlled, randomized Phase 3 trial evaluating 12-month kidney function in highly sensitized (cPRA =99.9%) kidney transplant patients with positive crossmatch against a deceased donor, comparing desensitization using imlifidase w ... Read more >

Status: Open Not Enrolling

Investigator: Mahwash Kassi

Study Coordinator: Jan-Michael Ragunton

Phone: 713.441.9837

To evaluate the efficacy of eplontersen compared to placebo for 120 weeks in patients with ATTR-CM receiving available standard of care (SoC). For more information, please visit https://www.cardio-ttransform.com. ... Read more >

Status: Enrolling

Investigator: Maen Abdelrahim

Study Coordinator: Fadi Abu-Shahin

Phone: 281.737.0435

We propose a regimen of six months neoadjuvant lenvatinib in combination with transcatheter arterial chemoembolization (TACE) prior to liver transplantation in patients with hepatocellular carcinoma (HCC) beyond Milan Criteria. Clinical, outcome ... Read more >